Application Area
Industry 4.0 has long become reality in many branches. In Pharma 4.0 intelligent industrial applications and IoT enable players in the bioeconomy industry to transition to operations that help them improve their productivity. Pharma 4.0 also has become a major part in single-use technologies, as it brings companies to the next level concerning the scalability, productivity and efficiency of their processes and products.
Michael Mühlegger
May 18, 2022
Application Area
CAR T-cell treatments are deservedly on the rise, as the effectiveness of CAR T-cell products for formerly hard to treat hematology malignancies has been established in clinical trials. This article will highlight one of the less discussed issues of immunotherapy in cancer treatment: it’s current price tag could hamper the broad accessibility to patients.
Michael Mühlegger
March 28, 2022
Application Area
Pharma 4.0 aims at improving risk management. It aims at updating the pharmaceutical industry and ensuring data integrity by incorporating advanced digital formats and enablers into the current Pharmaceutical Quality System (ICH Q10). The final goal is to minimize, if not eradicate, human error.
Michael Mühlegger
March 23, 2022
Application Area
Pharma 4.0 is the vision of digitalized pharmaceutical manufacturing. The implementation of modern digital strategies into the production of pharmaceutical goods promises increasing productivity, easier compliance, enhanced connectivity and improved data monitoring to take appropriate action early. Read more!
Michael Eder
March 9, 2022
Application Area
In a comprehensive study the impact of ice front growth speed on scalability of freezing protein solutions has been evaluated.
Michael Eder
February 15, 2022
Application Area
There is no full Pharma 4.0 manufacturing in place yet, but there are first innovations to build on.
Currently numerous manual handling steps in biopharmaceutical manufacturing come along with a high degree of failures in manufacturing facilities deriving from human errors in operative handling.
Michael Eder
January 20, 2022
Application Area
In order to allow for a smooth and functioning process, a reliable supply chain, tailored to the specific needs of autologous therapies, is a prerequisite. Single Use Support has developed an end-to-end process solution for cell and gene therapies.
Michael Eder
January 10, 2022
Application Area
Single Use Support develops scalable solutions and optimizes processes for protecting, fill & freeze, shockfreezing, packaging and handling of small volume cell and gene therapeutics. Learn more about logistics for CAR T-cell therapy!
Michael Eder
December 22, 2021
Application Area
Single Use Support is solving problems related to supply chain management through the development of smart packaging and related smart technologies for CAR T-cell therapy. Read more!
Brian Moloney
December 20, 2021
Application Area
Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. Accordingly, they can be classified into three main types, namely gene therapy, tissue engineered- and somatic-cell therapy medicines. Read more!
Michael Eder
December 20, 2021
Application Area
Cell and Gene therapies such as CAR T-cell therapy have proven their potential to become standard treatments to hard-to-treat diseases. Single Use Support has developed solutions for crucial challenges - read more!
Michael Mühlegger
December 2, 2021
Application Area
Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Ex Vivo and In Vivo are two different approaches you will learn about in this article!
Michael Mühlegger
December 2, 2021